PAWC
P.A.W. Capital Portfolio holdings
AUM
$51.9M
1-Year Return
46.14%
This Quarter Return
+20.13%
1 Year Return
+46.14%
3 Year Return
+74.13%
5 Year Return
+167.35%
10 Year Return
+839.74%
AUM
$90.1M
AUM Growth
+$1.72M
(+1.9%)
Cap. Flow
-$16M
Cap. Flow
% of AUM
-17.78%
Top 10 Holdings %
Top 10 Hldgs %
47.18%
Holding
64
New
5
Increased
15
Reduced
21
Closed
6
Top Buys
| 1 |
EverQuote
EVER
|
$1.35M |
| 2 |
Asure Software
ASUR
|
$906K |
| 3 |
Magnite
MGNI
|
$833K |
| 4 |
Goldman Sachs
GS
|
$603K |
| 5 |
APTO
Aptose Biosciences, Inc.
APTO
|
$602K |
Top Sells
| 1 |
Digital Turbine
APPS
|
$10.3M |
| 2 |
OptimizeRx
OPRX
|
$1.76M |
| 3 |
Cantaloupe
CTLP
|
$1.75M |
| 4 |
RCM
R1 RCM Inc. Common Stock
RCM
|
$1.46M |
| 5 |
Macy's
M
|
$1.31M |
Sector Composition
| 1 | Technology | 34.22% |
| 2 | Healthcare | 22.15% |
| 3 | Communication Services | 16.97% |
| 4 | Consumer Staples | 9.44% |
| 5 | Industrials | 4.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Galmed Pharmaceuticals
GLMD
$6.9M
| $706K | 0.77% |
1,111
+555
| +100% | +$353K |
|
27
Procter & Gamble
PG
$372B
| $695K | 0.76% |
5,000
| – | – |
|
28
PepsiCo
PEP
$202B
| $693K | 0.75% |
5,000
| – | – |
|
29
Philip Morris
PM
$254B
| $675K | 0.73% |
9,000
| – | – |
|
30
JPMorgan Chase
JPM
$830B
| $674K | 0.73% |
7,000
| – | – |
|
31
Johnson & Johnson
JNJ
$429B
| $670K | 0.73% |
4,500
| – | – |
|
32
Merck
MRK
$210B
| $664K | 0.72% |
8,384
-524
| -6% | -$41.5K |
|
33
Pfizer
PFE
$140B
| $661K | 0.72% |
18,972
-2,108
| -10% | -$73.4K |
|
34
Dow Inc
DOW
$16.6B
| $659K | 0.72% |
14,000
-2,000
| -13% | -$94.1K |
|
35
3M
MMM
$81.4B
| $641K | 0.7% |
4,784
| – | – |
|
36
Morgan Stanley
MS
$239B
| $629K | 0.68% |
13,000
-1,000
| -7% | -$48.4K |
|
37
AT&T
T
$211B
| $627K | 0.68% |
29,128
+1,324
| +5% | +$28.5K |
|
38
Altria Group
MO
$112B
| $618K | 0.67% |
16,000
| – | – |
|
39
Exxon Mobil
XOM
$477B
| $618K | 0.67% |
18,000
+3,000
| +20% | +$103K |
|
40
AbbVie
ABBV
$377B
| $613K | 0.67% |
7,000
| – | – |
|
41
Chevron
CVX
$318B
| $612K | 0.67% |
8,500
+1,500
| +21% | +$108K |
|
|
42
Goldman Sachs
GS
$223B
| $603K | 0.66% |
+3,000
| New | +$603K |
|
43
GSK
GSK
$79.5B
| $602K | 0.66% |
12,800
+800
| +7% | +$37.6K |
|
44
Kraft Heinz
KHC
$31.9B
| $599K | 0.65% |
20,000
| – | – |
|
45
Cisco
CSCO
$268B
| $591K | 0.64% |
+15,000
| New | +$591K |
|
46
BlackRock TCP Capital
TCPC
$610M
| $589K | 0.64% |
60,000
| – | – |
|
47
Ares Capital
ARCC
$15.7B
| $558K | 0.61% |
40,000
| – | – |
|
|
RDS.A
48
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $503K | 0.55% |
20,000
+2,000
| +11% | +$50.3K |
|
49
Coca-Cola
KO
$297B
| $494K | 0.54% |
10,000
| – | – |
|
50
Wells Fargo
WFC
$261B
| $470K | 0.51% |
20,000
-3,500
| -15% | -$82.3K |
|